Correlation Between Ultragenyx and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and ProQR Therapeutics BV, you can compare the effects of market volatilities on Ultragenyx and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and ProQR Therapeutics.
Diversification Opportunities for Ultragenyx and ProQR Therapeutics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ultragenyx and ProQR is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Ultragenyx i.e., Ultragenyx and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Ultragenyx and ProQR Therapeutics
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the ProQR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.37 times less risky than ProQR Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The ProQR Therapeutics BV is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 331.00 in ProQR Therapeutics BV on August 28, 2024 and sell it today you would earn a total of 23.00 from holding ProQR Therapeutics BV or generate 6.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultragenyx vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Ultragenyx |
| ProQR Therapeutics |
Ultragenyx and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultragenyx and ProQR Therapeutics
The main advantage of trading using opposite Ultragenyx and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
| ProQR Therapeutics vs. Eliem Therapeutics | ProQR Therapeutics vs. HCW Biologics | ProQR Therapeutics vs. Scpharmaceuticals | ProQR Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |